Web Analytics

3 Latest Announced Rounds

  • $4,200,000
    Seed

    5 Investors

    Technology, Information and Internet
    Jun 5th, 2025
  • $9,142,230
    Seed

    1 Investors

    Software Development
    Jun 5th, 2025
  • $13,700,350
    Series A

    1 Investors

    Software Development
    Jun 5th, 2025
$924.27M Raised in 54 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Genialis

start up
United States - Boston, MA
  • 30/03/2023
  • Series A
  • $13,000,000

Genialis is a computational precision medicines company unraveling complex biology to find new ways to address disease. Our mission is to deliver benefit and hope to patients and their families. Our method is to leverage biomedical data and advanced analytics to help pharma companies develop more effective drugs with higher probability of clinical success, and diagnostics companies to deploy tests that lead to better treatment decisions.


Related People

Rafael RosengartenFounder

Rafael Rosengarten United States - McClellanville, South Carolina

Leads Genialis’ effort to integrate and mine vast and diverse sources of biomedical knowledge to realize the promise of precision medicine and therapeutic discovery.